Table 1 Monitoring parameters in cohort of study
Parameters | Mean (SD) | N (%) |
|---|---|---|
Weight | 501 | |
Initial weight | 66.7 (12.8) | |
Last weight | 66.1 (13.1) | |
Weight Change | ||
Increase | - | 177 (35.3%) |
Decrease | - | 262 (52.3%) |
No change | - | 62 (12.4%) |
Fasting Plasma Glucose | 501 | |
Initial | 22.7 (116.3) | |
During | 8.4 (2.4) | |
Last | 8.2 (2.4) | |
HbA1c test | ||
Initial | 7.9 (1.8) | 123 (24.6) |
During | 7.9 (1.6) | 215 (42.9) |
Last | 8.2 (1.9) | 194 (38.7) |
Total Cholesterol | 501 | |
Initial | 63.5 (232.1) | |
During | 63.4 (152.0) | |
Last | 25.1 (139.1) | |
Triglycerides | 501 | |
Initial | 65.8 (243.9) | |
During | 27.8 (158.6) | |
Last | 19.7 (132.6) | |
Low-density Lipoprotein | 501 | |
Initial | 101.1 (295.9) | |
During | 45.3 (199.7) | |
Last | 39.1 (185.5) | |
High-density Lipoprotein | 501 | |
Initial | 67.1 (247.7) | |
During | 31.2 (170.2) | |
Last | 21.2 (139.7) | |
Alkaline Phosphatase-ALP | 501 | |
Initial | 158.3 (262.1) | |
During | 124.4 (197.8) | |
Last | 104.3 (159.4) | |
Alanine Transferase - ALT | 501 | |
Initial | 111.3 (276.1) | |
During | 70.1 (204.4) | |
Last | 50.0 (155.7) |